1	PGG-glucan	PGG-glucan	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	a	a	_	_	_	_	_	_	_
4	soluble	soluble	_	_	_	_	_	_	_
5	beta-(1,3)-glucan	beta-(1,3)-glucan	_	_	_	_	_	_	_
6	,	,	_	_	_	_	_	_	_
7	enhances	enhance	_	_	_	_	_	_	_
8	the	the	_	_	_	_	_	_	_
9	oxidative	oxidative	_	_	_	_	_	_	_
10	burst	burst	_	_	_	_	_	_	_
11	response	response	_	_	_	_	_	_	_
12	,	,	_	_	_	_	_	_	_
13	microbicidal	microbicidal	_	_	_	_	_	_	_
14	activity	activity	_	_	_	_	_	_	_
15	,	,	_	_	_	_	_	_	_
16	and	and	_	_	_	_	_	_	_
17	activates	activate	_	_	_	_	_	_	_
18	an	an	_	_	_	_	_	_	_
19	NF-kappa	NF-kappa	_	_	_	_	_	_	_
20	B-like	b-like	_	_	_	_	_	_	_
21	factor	factor	_	_	_	_	_	_	_
22	in	in	_	_	_	_	_	_	_
23	human	human	_	_	_	_	_	_	_
24	PMN	pmn	_	_	_	_	_	_	_
25	:	:	_	_	_	_	_	_	_
26	evidence	evidence	_	_	_	_	_	_	_
27	for	for	_	_	_	_	_	_	_
28	a	a	_	_	_	_	_	_	_
29	glycosphingolipid	glycosphingolipid	_	_	_	_	_	_	_
30	beta-(1,3)-glucan	beta-(1,3)-glucan	_	_	_	_	_	_	_
31	receptor	receptor	_	_	_	_	_	_	_
32	.	.	_	_	_	_	_	_	_

1	PGG-Glucan	PGG-Glucan	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	a	a	_	_	_	_	_	_	_
4	soluble	soluble	_	_	_	_	_	_	_
5	beta-(1,6)-branched	beta-(1,6)-branched	_	_	_	_	_	_	_
6	beta-(1,3)-linked	beta-(1,3)-linked	_	_	_	_	_	_	_
7	glucose	glucose	_	_	_	_	_	_	_
8	homopolymer	homopolymer	_	_	_	_	_	_	_
9	derived	derive	_	_	_	_	_	_	_
10	from	from	_	_	_	_	_	_	_
11	the	the	_	_	_	_	_	_	_
12	cell	cell	_	_	_	_	_	_	_
13	wall	wall	_	_	_	_	_	_	_
14	of	of	_	_	_	_	_	_	_
15	the	the	_	_	_	_	_	_	_
16	yeast	yeast	_	_	_	_	_	_	_
17	Saccharomyces	saccharomyces	_	_	_	_	_	_	_
18	cerevisiae	cerevisiae	_	_	_	_	_	_	_
19	,	,	_	_	_	_	_	_	_
20	is	be	_	_	_	_	_	_	_
21	an	an	_	_	_	_	_	_	_
22	immunomodulator	immunomodulator	_	_	_	_	_	_	_
23	which	which	_	_	_	_	_	_	_
24	enhances	enhance	_	_	_	_	_	_	_
25	leukocyte	leukocyte	_	_	_	_	_	_	_
26	anti-infective	anti-infective	_	_	_	_	_	_	_
27	activity	activity	_	_	_	_	_	_	_
28	and	and	_	_	_	_	_	_	_
29	enhances	enhance	_	_	_	_	_	_	_
30	myeloid	myeloid	_	_	_	_	_	_	_
31	and	and	_	_	_	_	_	_	_
32	megakaryocyte	megakaryocyte	_	_	_	_	_	_	_
33	progenitor	progenitor	_	_	_	_	_	_	_
34	proliferation	proliferation	_	_	_	_	_	_	_
35	.	.	_	_	_	_	_	_	_

1	Incubation	incubation	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	human	human	_	_	_	_	_	_	_
4	whole	whole	_	_	_	_	_	_	_
5	blood	blood	_	_	_	_	_	_	_
6	with	with	_	_	_	_	_	_	_
7	PGG-Glucan	PGG-Glucan	_	_	_	_	_	_	_
8	significantly	significantly	_	_	_	_	_	_	_
9	enhanced	enhance	_	_	_	_	_	_	_
10	the	the	_	_	_	_	_	_	_
11	oxidative	oxidative	_	_	_	_	_	_	_
12	burst	burst	_	_	_	_	_	_	_
13	response	response	_	_	_	_	_	_	_
14	of	of	_	_	_	_	_	_	_
15	subsequently	subsequently	_	_	_	_	_	_	_
16	isolated	isolate	_	_	_	_	_	_	_
17	blood	blood	_	_	_	_	_	_	_
18	leukocytes	leukocyte	_	_	_	_	_	_	_
19	to	to	_	_	_	_	_	_	_
20	both	both	_	_	_	_	_	_	_
21	soluble	soluble	_	_	_	_	_	_	_
22	and	and	_	_	_	_	_	_	_
23	particulate	particulate	_	_	_	_	_	_	_
24	activators	activator	_	_	_	_	_	_	_
25	in	in	_	_	_	_	_	_	_
26	a	a	_	_	_	_	_	_	_
27	dose-dependent	dose-dependent	_	_	_	_	_	_	_
28	manner	manner	_	_	_	_	_	_	_
29	,	,	_	_	_	_	_	_	_
30	and	and	_	_	_	_	_	_	_
31	increased	increase	_	_	_	_	_	_	_
32	leukocyte	leukocyte	_	_	_	_	_	_	_
33	microbicidal	microbicidal	_	_	_	_	_	_	_
34	activity	activity	_	_	_	_	_	_	_
35	.	.	_	_	_	_	_	_	_

1	No	no	_	_	_	_	_	_	_
2	evidence	evidence	_	_	_	_	_	_	_
3	for	for	_	_	_	_	_	_	_
4	inflammatory	inflammatory	_	_	_	_	_	_	_
5	cytokine	cytokine	_	_	_	_	_	_	_
6	production	production	_	_	_	_	_	_	_
7	was	be	_	_	_	_	_	_	_
8	obtained	obtain	_	_	_	_	_	_	_
9	under	under	_	_	_	_	_	_	_
10	these	these	_	_	_	_	_	_	_
11	conditions	condition	_	_	_	_	_	_	_
12	.	.	_	_	_	_	_	_	_

1	Electrophoretic	electrophoretic	_	_	_	_	_	_	_
2	mobility	mobility	_	_	_	_	_	_	_
3	shift	shift	_	_	_	_	_	_	_
4	assays	assay	_	_	_	_	_	_	_
5	demonstrated	demonstrate	_	_	_	_	_	_	_
6	that	that	_	_	_	_	_	_	_
7	PGG-Glucan	PGG-Glucan	_	_	_	_	_	_	_
8	induced	induce	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	activation	activation	_	_	_	_	_	_	_
11	of	of	_	_	_	_	_	_	_
12	an	an	_	_	_	_	_	_	_
13	NF-kappaB-like	nf-kappab-like	_	_	_	_	_	_	_
14	nuclear	nuclear	_	_	_	_	_	_	_
15	transcription	transcription	_	_	_	_	_	_	_
16	factor	factor	_	_	_	_	_	_	_
17	in	in	_	_	_	_	_	_	_
18	purified	purify	_	_	_	_	_	_	_
19	human	human	_	_	_	_	_	_	_
20	neutrophils	neutrophil	_	_	_	_	_	_	_
21	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	binding	binding	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	3H-PGG-Glucan	3H-PGG-Glucan	_	_	_	_	_	_	_
5	to	to	_	_	_	_	_	_	_
6	human	human	_	_	_	_	_	_	_
7	leukocyte	leukocyte	_	_	_	_	_	_	_
8	membranes	membrane	_	_	_	_	_	_	_
9	was	be	_	_	_	_	_	_	_
10	specific	specific	_	_	_	_	_	_	_
11	,	,	_	_	_	_	_	_	_
12	concentration-dependent	concentration-dependent	_	_	_	_	_	_	_
13	,	,	_	_	_	_	_	_	_
14	saturable	saturable	_	_	_	_	_	_	_
15	,	,	_	_	_	_	_	_	_
16	and	and	_	_	_	_	_	_	_
17	high	high	_	_	_	_	_	_	_
18	affinity	affinity	_	_	_	_	_	_	_
19	(	(	_	_	_	_	_	_	_
20	Kd	Kd	_	_	_	_	_	_	_
21	approximately	approximately	_	_	_	_	_	_	_
22	6	6	_	_	_	_	_	_	_
23	nM	nm	_	_	_	_	_	_	_
24	)	)	_	_	_	_	_	_	_
25	.	.	_	_	_	_	_	_	_

1	A	a	_	_	_	_	_	_	_
2	monoclonal	monoclonal	_	_	_	_	_	_	_
3	antibody	antibody	_	_	_	_	_	_	_
4	specific	specific	_	_	_	_	_	_	_
5	to	to	_	_	_	_	_	_	_
6	the	the	_	_	_	_	_	_	_
7	glycosphingolipid	glycosphingolipid	_	_	_	_	_	_	_
8	lactosylceramide	lactosylceramide	_	_	_	_	_	_	_
9	was	be	_	_	_	_	_	_	_
10	able	able	_	_	_	_	_	_	_
11	to	to	_	_	_	_	_	_	_
12	inhibit	inhibit	_	_	_	_	_	_	_
13	activation	activation	_	_	_	_	_	_	_
14	of	of	_	_	_	_	_	_	_
15	the	the	_	_	_	_	_	_	_
16	NF-kappaB-like	nf-kappab-like	_	_	_	_	_	_	_
17	factor	factor	_	_	_	_	_	_	_
18	by	by	_	_	_	_	_	_	_
19	PGG-Glucan	PGG-Glucan	_	_	_	_	_	_	_
20	,	,	_	_	_	_	_	_	_
21	and	and	_	_	_	_	_	_	_
22	ligand	ligand	_	_	_	_	_	_	_
23	binding	binding	_	_	_	_	_	_	_
24	data	datum	_	_	_	_	_	_	_
25	,	,	_	_	_	_	_	_	_
26	including	include	_	_	_	_	_	_	_
27	polysaccharide	polysaccharide	_	_	_	_	_	_	_
28	specificity	specificity	_	_	_	_	_	_	_
29	,	,	_	_	_	_	_	_	_
30	suggested	suggest	_	_	_	_	_	_	_
31	that	that	_	_	_	_	_	_	_
32	the	the	_	_	_	_	_	_	_
33	PGG-Glucan	pgg-glucan	_	_	_	_	_	_	_
34	binding	binding	_	_	_	_	_	_	_
35	moiety	moiety	_	_	_	_	_	_	_
36	was	be	_	_	_	_	_	_	_
37	lactosylceramide	lactosylceramide	_	_	_	_	_	_	_
38	.	.	_	_	_	_	_	_	_

1	These	these	_	_	_	_	_	_	_
2	results	result	_	_	_	_	_	_	_
3	indicate	indicate	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	PGG-Glucan	PGG-Glucan	_	_	_	_	_	_	_
6	enhances	enhance	_	_	_	_	_	_	_
7	neutrophil	neutrophil	_	_	_	_	_	_	_
8	anti-microbial	anti-microbial	_	_	_	_	_	_	_
9	functions	function	_	_	_	_	_	_	_
10	and	and	_	_	_	_	_	_	_
11	that	that	_	_	_	_	_	_	_
12	interaction	interaction	_	_	_	_	_	_	_
13	between	between	_	_	_	_	_	_	_
14	this	this	_	_	_	_	_	_	_
15	beta-glucan	beta-glucan	_	_	_	_	_	_	_
16	and	and	_	_	_	_	_	_	_
17	human	human	_	_	_	_	_	_	_
18	neutrophils	neutrophil	_	_	_	_	_	_	_
19	is	be	_	_	_	_	_	_	_
20	mediated	mediate	_	_	_	_	_	_	_
21	by	by	_	_	_	_	_	_	_
22	the	the	_	_	_	_	_	_	_
23	glycosphingolipid	glycosphingolipid	_	_	_	_	_	_	_
24	lactosylceramide	lactosylceramide	_	_	_	_	_	_	_
25	present	present	_	_	_	_	_	_	_
26	at	at	_	_	_	_	_	_	_
27	the	the	_	_	_	_	_	_	_
28	cell	cell	_	_	_	_	_	_	_
29	surface	surface	_	_	_	_	_	_	_
30	.	.	_	_	_	_	_	_	_

